论文部分内容阅读
目的观察达英-35联合二甲双胍治疗多囊卵巢综合征的临床效果。方法随机抽取我院自2015年5月至2016年5月收治的多囊卵巢综合征患者60例,将其分为实验组和对照组,每组30例。实验组采用达英-35进行治疗,对照组在实验组的基础上联用二甲双胍。而后对比两组患者治疗后的总有效率以及治疗前后的性激素水平。结果甲组的总有效率(93.3%)明显高于乙组的(73.3%),差异显著,具有统计学意义(P<0.05);治疗前,两组患者的性激素水平无显著差异,无统计学意义(P>0.05);治疗后,甲组的性激素水平明显优于乙组的,差异显著,具有统计学意义(P<0.05)。结论达英-35联合二甲双胍治疗多囊卵巢综合征取得的了临床效果显著,有效的改善了患者的性激素水平,值得进一步推广和使用。
Objective To observe the clinical effect of Da Ying-35 combined with metformin in the treatment of polycystic ovary syndrome. Methods Sixty patients with polycystic ovary syndrome who were admitted to our hospital from May 2015 to May 2016 were randomly divided into experimental group and control group, with 30 cases in each group. The experimental group was treated with up to -35, and the control group was treated with metformin on the basis of the experimental group. Then compare the two groups of patients after treatment, the total effective rate and sex hormone levels before and after treatment. Results The total effective rate (93.3%) in group A was significantly higher than that in group B (73.3%), with significant difference (P <0.05). Before treatment, there was no significant difference in sex hormone levels between the two groups (P> 0.05). After treatment, the level of sex hormone in group A was significantly better than that in group B, with significant difference (P <0.05). Conclusions Da-Ying-35 combined with metformin in the treatment of polycystic ovary syndrome achieved a significant clinical effect, effectively improving the patient’s sex hormone levels, worthy of further promotion and use.